Candela and MT.DERM Sign Exclusive Collaboration Agreement

Under the terms of the agreement, Candela will commercialize the Exceed medical microneedling system globally, with a first launch in the U.S. Photo credit: Candela Corporation

Candela Corporation has entered into an exclusive collaboration agreement with MT.DERM GmbH for the commercialization of MT.DERM's medical microneedling products. Under the terms of the agreement, Candela will commercialize the Exceed medical microneedling system globally, with a first launch in the U.S. The Exceed system from MT.DERM is the world's only dual-indicated, FDA-cleared medical microneedling device. It is clinically proven to dramatically reduce the appearance of facial wrinkles and facial acne scars. Candela manufactures and distributes the Profound system, the only real-time, temperature-controlled, long pulse radiofrequency (RF) microneedling device. "We are delighted to enter into a partnership with MT.DERM, based on its superior engineering and deep understanding of needling technology," said Geoffrey Crouse, CEO of Candela.  "Microneedling is an essential component of any medical aesthetics practice.  The addition of the Exceed medical microneedling system strengthens Candela's product portfolio, which continues to provide customers the most comprehensive offering of best-in-class medical aesthetic technologies."

RELATED STORIES

The Skin Saint Predicts the Top 2020 Med Spa Trends

Three Types of Microneedling Treatments Explained

Everything You Need to Know About Microneedling

Suggested Articles

The two companies have joined forces to develop three distinct treatment services that will broaden menu offerings and increase revenue.

Upgraded packaging, deluxe labels, and new products are now available.

WalletHub has released a list ranking the healthiest and unhealthiest cities in America.